Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
- Arrayit
- Clinical
- Corporate
- Board of Directors
- Rene Schena
- Contact Us
- Arrayit Corporation Distributors
- Microarray Employment
- Legal Information
- Microarray Management Team
- Microarray Media & Press
- Arrayit Corporation Appoints Apple Enterprise Healthcare Partner to Accelerate FY2019 Revenues and Earnings Growth
- Arrayit Corporation Increases Weekly Guidance for Doctor-Prescribed Allergy Testing Clinical Services
- Arrayit Corporation Announces In-Network Allergy Testing Services Contract with a Top Five CoCommercial Healthcare Benefits Company
- Arrayit Corporation Nationwide Allergy Testing Network Doubles to More than 400 Healthcare Clinics
- Arrayit Corporation Allergy Testing Services Endorsed by Leading Pediatrics Medical Group
- Arrayit Corporation Aces Fourth Consecutive Round of Proficiency Testing with a Top Proficiency Testing Company
- Arrayit Corporation Announces Chief Executive Officer Letter to Shareholders
- Arrayit Corporation Fulfills Clinical Instrumentation Contract with the United States Food and Drug Administration
- Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider
- Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing
- Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business
- Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics
- Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists
- Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration
- Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services
- Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
- Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain
- Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics
- Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration
- Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network
- Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement
- Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists
- Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services
- Arrayit Corporation Receives Approval for Ten Million Share Dividend in AVDX Stock to ARYC Shareholders
- Arrayit Corporation Awards $3M Stock Dividend to ARYC Shareholders
- Arrayit Corporation and Vivos Team Up on Global Genome Vault
- Arrayit and USDA Expanding Patent Protection for Food Safety Testing Worldwide
- Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog
- Arrayit Corporation Subsidiary Avant Diagnostics, Inc. Acquired by American Liberty Petroleum Corporation
- Arrayit Corporation Signs Cooperative Research and Development Agreement with the United States Department of Agriculture
- Arrayit Corporation Showcases High Sensitivity Diagnostic Microarray Technology at 21st International Molecular Medicine Tri-Conference
- Arrayit Corporation Showcases Advanced Robotic Microarray Technology at Laboratory Automation Conference 2014
- Arrayit Corporation Participates in the International Plant and Animal Genome Conference XXII; Hosts Technology Workshop “Breakthroughs in Microarray Technology”
- Arrayit Corporation Commences Business Operations from New Sunnyvale Headquarters
- Arrayit Corporation Announces Life Sciences Instrument Sale to Top Research Center in Ontario
- Arrayit Corporation Announces Microarray Platform Sale to Leading Laboratory in Israel
- Arrayit Corporation To Work With Diagnostic Oncology Research Organization (DOCRO) To Obtain FDA Approvals
- Arrayit Corporation Engages Professional Services of Diagnostic Oncology Research Organization
- Arrayit Corporation To Host Conference Call To Discuss Third Quarter 2013 Results
- Arrayit Corporation Receives Contract Award From the Department of Veterans Affairs
- Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
- Arrayit Corporation Signs Exclusive Distributorship Agreement With DHK Medical Products for Genome Testing in India
- Arrayit Diagnostics Files S-1 Registration Statement
- Arrayit Diagnostics, Inc. Announces $8 Million Financing Commitment
- Arrayit Corporation Posts 60% Quarterly Sales Increase
- Arrayit Diagnostics, Inc. Reports Results of Research Study for Ovarian Cancer Diagnostic Test
- Arrayit Spokesperson Khrystyne Haje to Appear on Rachael Ray to Support Cancer Patients in Treatment
- Arrayit Corporation Announces Stock Dividend Distribution Date for Shareholders
- Arrayit's CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses
- Arrayit Corporation to Spin-Off Arrayit Diagnostics, Inc. to Shareholders
- Arrayit Corporation Reports 47% Revenue Growth. Life Science Tools and Services Provide Key Sales Drivers in Record Quarter.
- Arrayit Corporation Announces the Product Launch of OvaDx(R), the Market's First Pre-Symptomatic Screening Test for Ovarian Cancer
- Arrayit Corporation Completes Proteomics Platform Installation and Training at the National Institutes of Health
- Arrayit Corporation Announces Premarket Approval (PMA) Submission Strategy for OvaDx®
- Arrayit Corporation Adds 128 New Products to Its Life Sciences Tools Portfolio
- Arrayit Corporation Taps Former IVAX Diagnostics Executive to Build Strategic Partnerships
- Arrayit Corporation Receives Registered Trademark for OvaDx(R)
- Arrayit Corporation Technology May Provide Vital Clues to Detoxification of the Oceans
- Arrayit Corporation Reports Strong Surge in Customer Demand for the Company's Leading Edge Life Sciences Microarray Instruments
- Arrayit Corporation to Present at Southern California Investment Association Summer Capital Conference
- Arrayit Achieves Significant Progress in First Quarter 2010
- Arrayit Corporation Taps DOCRO, Inc. to Facilitate FDA Approval of OvaDx
- Arrayit Corporation Completes Installation of Patented Manufacturing Technology in Russia
- Arrayit Corporation President Dr. Mark Schena to Appear Live on the Television Program the Big Biz Show
- Arrayit Corporation Has Discovered a Pathway to True Health Care Reform With Pre-symptomatic Diagnostics
- Arrayit Wins Landmark DNA Testing Patent in Israel
- Arrayit Corporation Proteomic Biomarkers Clear the Way for Pre-Symptomatic Detection of Ovarian Cancer and Other Major Diseases
- Arrayit Corporation Selected by Silicom Ventures to Present at the 2010 Personalized Medicine World Conference in Silicon Valley
- Major News Media Missed the Mark -- There Is a New Pre-Symptomatic Screening Test for Ovarian Cancer Coming From Arrayit Corporation, and It Will Be Available Soon
- Arrayit Corporation Announces Manufacturing Breakthrough
- Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010
- Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
- Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics
- Arrayit Diagnostics Names Elite Financial Communications Group as Investor Relations/Public Relations Counsel
- Arrayit Technology Purchased by Johns Hopkins University to Study Rheumatoid Arthritis
- Arrayit Diagnostics Focused on Early Stage Disease Detection
- Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments
- Arrayit Corporation Blood Tests Diagnose Early Stage Cancers and Communicable Diseases
- Arrayit Announces NanoPrint Sale to Leukemia Center in Poland
- Arrayit and the USDA Join Forces to Protect America's Crop Plants
- Will Arrayit Technology Identify Life on Mars?
- Arrayit Corporation CEO Reports to Shareholders
- Arrayit Deploys Next-Generation Proteomics Platform
- Arrayit Wins Contract With Austrian Institute of Technology for Detection of Highly Dangerous Pathogens
- Arrayit Wins Equipment Contract From Sandia National Laboratories
- Arrayit Wins Manufacturing Contract From the Centers for Disease Control
- Arrayit Offers Million Dollar Biomarker Discovery Service
- Arrayit Lands Patent for Population Scale Diagnostics in World's Most Populous Country
- Arrayit Corporation Speeds Allergy Testing
- Arrayit Corporation Opens International Marketing Headquarters in Houston
- Arrayit Corporation Announces 50% Sales Increase
- Arrayit and Parkinson's Institute Implement New Techniques
- Mark Schena Arrayit VIP Technology for Diagnostics
- Arrayit Flu Pandemic
- H1N1 Swine Flu Test Chip
- Arrayit Speeds Analysis of Human Genome
- Arrayit and The Parkinson's Institute
- Arrayit Ticker ARYC
- Arrayit Licensing
- Arrayit BSI Alliance
- Arrayit President
- Arrayit Acquisition
- Arrayit Merger
- Arrayit Goes Green
- Arrayit Lab Automation
- SpotBot 2 Interstitial
- Arrayit Platform
- NanoPrint Facility
- Website Renovation
- Arrayit Distributors
- Custom Microarrays
- Clinical Microarrays
- FDA MAQC
- Sales Increase
- Biacore
- New Zealand Patent
- Singapore Patent
- Shop Site
- Schena 2005
- Orange Packing
- Carbohydrate Microarray
- Schena Patent
- Silicon Valley
- Sales
- WebTraffic
- Chips-to-Hits
- Arrayit cNBC
- Arrayit Protein Biochips
- Amazon PR
- New Accounts
- The Scientist
- Rising Star
- Silicon Valley 50
- Inc 500 2003
- Signet Research
- Oxford Press
- Nature
- PharmaGenomics
- Publication Award
- Pittcon
- Rising Star
- Inc 500 2002
- New York Times
- Mark Schena
- Scientific Advisors
- Arrayit News
- Diagnostics
- Investors
- Arrayit Technology
- ARYC Big Biz ShowTM
- Arrayit Biochemistry 101
- Arrayit Board of Directors
- Arrayit Corporation Business Summary
- Arrayit Corporation ARYC Celebrity Spokesperson Khrystyne Haje
- ARYC Central Index Key
- Rene Schena
- Arrayit Code of Ethics
- Arrayit Company Overview
- Conference Calls
- Arrayit Customers
- Investor Glossary
- ARYC Investor Contacts
- Arrayit Letter to Shareholders from the CEO
- ARYC Live Television
- Arrayit Management Team
- Arrayit Medical Breakthrough
- Arrayit Newsletter
- Arrayit Newsletter 2
- Arrayit Personalized Medicine
- Arrayit Press Releases
- ARYC SEC Filings
- ARYC Sector and Industry
- ARYC SIC Code
- Arrayit Standard & Poor's
- ARYC Stock Price
- ARYC Stock Volume
- Arrayit Corporation Subsidiaries
- ARYC Transfer Agent
- Arrayit The Wall Street Transcript
- Arrayit XBRL
- Products
- Microarray Labeling
- Microarray Software
- Microarray Buffers
- Chemicals
- DNA Microarrays
- Microarray Cleanrooms
- Microarrayers
- Microarray Instruments
- Hybridization Station
- Microarray Computer
- Microarray Air Jet
- Microarray Centrifuges
- Microarray Hybridization Station
- Microarray Imprinter
- Microarray Microscope
- Microarray Vacuum Packing
- Liquid Handler
- Microarray Pin Cleaning
- Microfluidic Controller
- Microplate Centrifuge
- Ozone Free Box
- Peptide Synthesis
- Protein Microarray Platform
- SpectraDrop
- Vacuum Pump
- Vacuum Pumps
- Microarray Platforms
- Microarray Printing
- Microarray Pins 192 Technology
- Microarray Pins 946 Technology
- Microarray Printheads BioRobotics
- Microarray Pins ChipMaker Technology
- Microarray Printheads Genetix
- Microarray Pins Green Technology
- Microarray Printing Demonstration
- Microarray Printheads NanoPrint
- Microarray Pins
- Microarray Printheads RoboDesign
- Microarray Pins Stealth Technology
- Microarray Printing Technical Guide
- Whole Cell Microarray Printing Pins
- Bio-Rad Calligrapher
- Microarray Scanners
- Microarray Slides
- Microarray Slides
- CEL slides
- Cover Slips
- Glass Bottom Microplates
- Hydrogel Slides
- Microplate Glass
- Microarray Mirror Slides
- Microarray ProPlate Glass
- Microarray Substrate Protein A/G
- Microarray Slides Sputtered Thin Films
- Aldehyde Slides
- Amine Slides
- Avidin Slides
- Glass Substrates
- Epoxy Slide
- Epoxy Slides
- Gold Coated Glass
- Multi-Well Slide
- Multi-Well Slides
- Multi-Well Substrates
- NHS Slides
- Nitrocellulose Slides
- Microarray Slides SuperNylon
- Protein Slides
- Microarray Slides SuperPVDF
- Streptavidin Slides
- Microfluidics
- Microarray Tools
- Protein Microarrays
- DNA Purification
- Microarray Products
- Services
- Arrayit Catalogs
- Microarray Movies
- Biomarkers
- Microarray Consulting
- Custom H25K Microarrays
- Microarray eChips
- Microarray Flex-Chips
- Microarray GSA Advantage
- Microarray E-Library
- Microarray Printing
- Microarray Protocols
- Oligonucleotide Synthesis
- Peptide Microarrays
- Protein Microarrays
- Reverse Phase Microarray
- Microarray Scanning Services
- SNP Genotyping
- Stem Cell
- Synthetic Biology
- Microarray Videos
- Blood Cards
- Microarray Hybridization AHC1X24
- In Situ Hybridization
- Microarray Hybridization Cassette
- Microarray Hyb Wash Dry
- Microarray Printing
- Microarray SpotBot Peristaltic Pump
- Colorimetric Microarray SpotWare Software
- Microarray SpotBot Multi-Well
- Microarray Dry
- Personal Microarrayer
- Microarray Scanner
- Multiplexing Assays
- Microarray Hybridization
- Microarray Slides
- Multiplex Assays
- Multiplex Hybridization
- Microarray Wash
- Microarray Spotter
- Tissue Microarrayer
- Well Plate Microarrays
- Protein Microarray
- Serum Separation
- Store
Investors - Conference Calls
Arrayit Corporation (Arrayit) is a leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function, clinical testing and diagnostics. The company hosts quarterly conference calls to present quarterly and annual financial results, and provide updates on the most recent quarter as well as financial guidance for the upcoming quarter. Please click on the links below to access our conference call transcripts. We anticipate resuming conference calls as soon as we become financially current. We anticipate filing our financials during the second quarter of 2019 (Q2-2019).
Fiscal Year-2014 Conference Call
Click here for webcast details
Event Date: 4/22/2015
Event Time: 11:00 AM Eastern
Event Title: Fiscal Year 2014 Earnings Conference Call
Live Participant Dial In (Toll Free): 877-407-0782
Live Participant Dial In (International): 201-689-8567
|
Conference |
Date |
Webcast |
Transcript |
|
FY-2014 |
April 22, 2015 |
Re-play audio |
Download PDF |
|
Q3-2014 |
November 26, 2014 |
Re-play audio |
Download PDF |
|
Q2-2014 |
August 26, 2014 |
Re-play audio |
Download PDF |
|
Q1-2014 |
May 20, 2014 |
Re-play audio |
Download PDF |
|
FY-2013 |
April 16, 2014 |
Re-play audio |
Download PDF |
|
Q3-2013 |
November 15, 2013 |
Re-play audio |
Download PDF |
Forward Looking Statements
Some information contained in or incorporated by reference into this website are forward looking statements within the meaning of the United States private securities litigation reform act of 1995. All forward-looking statements involve risks and uncertainties. In particular, any statements regarding pro-forma finances, future sales, results of operations, operating efficiencies and product expansion are subject to known and unknown risks, uncertainties and contingencies. Many of these risks, uncertainties and contingencies are beyond the control of the company and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. Accordingly, you should not place undue reliance on the forward-looking statements contained in this website. These forward-looking statements speak only as of the date on which the statements were made. In evaluating forward-looking statements, you should consider these risks and uncertainties. The company does not assume any obligation to update any such forward-looking statements to reflect events or circumstances after the date of posting of this information.
Copyright 1993-2019 Arrayit Corporation. All rights reserved.